Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?
نویسندگان
چکیده
منابع مشابه
Atrial fibrillation in heart failure: what should we do?
Heart failure (HF) and atrial fibrillation (AF) are two conditions that are likely to dominate the next 50 years of cardiovascular (CV) care. Both are increasingly prevalent and associated with high morbidity, mortality, and healthcare cost. They are closely inter-related with similar risk factors and shared pathophysiology. Patients with concomitant HF and AF suffer from even worse symptoms an...
متن کاملAtrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention.
With the introduction of the target-specific oral anticoagulants (TSOAs), primary and secondary stroke prevention in atrial fibrillation (AF) has been revolutionized. Large randomized clinical trials and subsequent meta-analyses have clearly demonstrated that these agents have at least comparable if not superior efficacy and cause no more or even less major bleeding than vitamin K antagonists. ...
متن کاملAtrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure.
AIMS Atrial fibrillation (AF) is a risk factor for death in patients with a myocardial infarction, but highly variable results are reported in patients with heart failure. We studied the prognostic impact of AF in heart failure patients with and without ischaemic heart disease. METHODS AND RESULTS During a period of 2 years, 3587 patients admitted to hospital because of heart failure were inc...
متن کاملUse of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
A trial fibrillation (AF) is the most common cardiac arrhythmia. It was estimated to affect up to 6.1 million Americans in 2010, and since AF is more common with increasing age, it is predicted to affect 12.1 million in the United States by 2030. AF increases the risk of stroke 5-fold across all age groups, and AF-related stroke incidence ranges from <1% to >20% per year in the absence of antic...
متن کاملUse of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
A trial fibrillation (AF) is the most common cardiac arrhythmia. It was estimated to affect up to 6.1 million Americans in 2010, and since AF is more common with increasing age, it is predicted to affect 12.1 million in the United States by 2030. AF increases the risk of stroke 5-fold across all age groups, and AF-related stroke incidence ranges from <1% to >20% per year in the absence of antic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal Supplements
سال: 2020
ISSN: 1520-765X,1554-2815
DOI: 10.1093/eurheartj/suaa159